Navigation Links
MiMedx Group Announces Temporary Trading Symbol Designation
Date:2/22/2010

ATLANTA, Feb. 22 /PRNewswire-FirstCall/ -- MiMedx Group, Inc. (OTC Bulletin Board: MDXG) has received numerous inquiries regarding the temporary change of its symbol to "MDXGE.OB" rather than "MDXG.OB".  This resulted from the change of the Company's fiscal year to a calendar year, as reported on form 8-K filed December 21, 2009.  The matter has been resolved and the OTC:BB has advised the Company that its stock will resume trading under "MDXG.OB" on Tuesday, February 23. Until such time, as was the case today, the Company's shares may be traded using the temporary symbol.

About MiMedx Group, Inc.

MiMedx Group, Inc. is an integrated developer, manufacturer and marketer of patent protected biomaterial-based products and is in the process of transitioning from a development-focused concern to an operating company focused on sales growth and profitability. The Company's assets include intellectual property protecting a collagen-based technology for augmentation
'/>"/>

SOURCE MiMedx Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. MiMedx Group, Inc. Adds Ronald G. Wallace to Board of Directors
2. MiMedx Group Announces Post-split Name Change
3. MiMedx Announces Brian J. Splan as President
4. Alynx, Co. Completes Merger With Medical Device Company MiMedx, Inc.
5. Anpath Group, Inc. Announces Fiscal 2010 Third Quarter Results
6. Encorium Group, Inc. Announces One-for-Eight Reverse Stock Split
7. Invida Selects LaVoie Group as Public Relations Agency of Record
8. Michael Langley, DVM, MBA, RAC Joins the Anson Group as a Regulatory Consultant
9. China YCT International Group, Inc. Announces That the State Intellectual Property Office of the Peoples Republic of China has Approved a Patent to its Operating Subsidiary, Shandong Spring Pharmaceutical Co. Ltd.
10. Danaher Completes Offer for Genetix Group plc
11. Lori Kahler Appointed President of The RC Insight Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... CASI Pharmaceuticals, Inc. (Nasdaq: CASI ... and commercialization of innovative therapeutics addressing cancer and other ... primary commercial focus on China , ... C meeting with the U.S. Food and Drug Administration ... February 2015.  During this meeting the Company will seek ...
(Date:12/15/2014)... METTLER TOLEDO is pleased to announce ... V19 with PVM technology , is now available. ... measurement tool continuously captures high-resolution images under a ... automatically prepares a report pairing the most relevant ... changes. This compelling blend of high resolution images ...
(Date:12/15/2014)... , Dec. 15, 2014  GlassesOff Inc. (OTCBB: GLSO) ... as an independent director of the Company,s Board ... AeroScout and served as its CEO until its acquisition ... a $240 million transaction. Recognized as the inventor of ... leadership, AeroScout provided Wi-Fi -based RFID solutions focused on ...
(Date:12/13/2014)... December 13, 2014 CanDiag, Inc., a ... company has changed its name to OncoTab, Inc. ... of where we are today,” said CEO and Chief ... platform’s applications beyond breast cancer diagnostics to include imaging ... of that evolution.” , Founded in 2011 by Dr. ...
Breaking Biology Technology:CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5New Real-Time In Situ Probe-Based Video Microscope from METTLER TOLEDO 2AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3CanDiag Inc. Expands Product Scope Under a New Name: OncoTab, Inc. 2
... TRBN ) today announced that executives will present a ... investor conferences in,February and March: , ... Waldorf Astoria, 301 Park,Ave., in New York City. Peter Thompson, ... 9 a.m. EST. A replay of the webcast will,be available ...
... 3 .decimal, Inc. announced today that,it has ... to supply,patient-specific devices for its proton therapy facility ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090203/CLTU104LOGO ) , ... a formal agreement signed with ProCure to be,their ...
... Shows Patients Consistently Adhere to Sleep Apnea TreatmentSAN ... that an internal study has shown their patients ... rate nearly twice the industry average.Analysis performed in ... received home sleep testing and treatment with Positive ...
Cached Biology Technology:Trubion Announces Presentations at Upcoming Investor Conferences 2ProCure Signs Agreement with .decimal, Inc. to Purchase Patient-Specific Devices for Its Proton Therapy Center in Oklahoma City 2SleepQuest Compliance Again Doubles Industry Average 2
(Date:12/11/2014)... ST. PAUL, Minn. , Dec. 10, 2014 ... in wireless physiologic monitoring, has released a new ... changing needs of preclinical toxicology researchers. M series, ... to help toxicologists collect the best possible physiologic ... studies. Adding functional endpoints to toxicology ...
(Date:12/10/2014)... 2014 Research and Markets ( ... "Biometrics Market in Japan 2014-2018" report ... http://photos.prnewswire.com/prnh/20130307/600769 The integration of biometrics ... banking and upgradation of the driver,s license is ... market. Besides the aforementioned projects, biometrics is being ...
(Date:12/3/2014)...   Marvin Test Solutions , a trusted ... military, aerospace, and manufacturing organizations, today announced the ... TS-900 PXI semiconductor test platform . The TS-960 ... to customers at a fraction of the footprint ... "Our semiconductor customers asked for ...
Breaking Biology News(10 mins):New telemetry implants expected to change how large animal toxicology studies are conducted 2Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3
... researchers harness the body,s own defenses to counteract nerve ... to pesticides and other poisons. The grant, from ... grant and establishes a new Center of Excellence at ... U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) ...
... Minnesota study reveals that the release of treated ... highest-quality treatment technology can have a significant ... referred to as "superbacteria," in surface waters. ... standard technologies probably contains far greater quantities of ...
... new series of article-chapters to be published in the ... better access the wealth of research knowledge obtained on ... function. The series will be authored by top geneticists ... aspects of modern yeast research and its applications to ...
Cached Biology News:Researchers get $7.5M grant to combat nerve agents 2Researchers get $7.5M grant to combat nerve agents 3New study finds that even the cleanest wastewater contributes to more 'super bacteria' 2YeastBook, the Eukaryotic Cell Encyclopedia is launched by Genetics 2
Lentigen's manufacturing platform is sufficiently versatile for use in the manufacture of any HIV-based Lentiviral vector. Lentigen will manufacture your LV of choice to the highest possible titer a...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Biology Products: